2023 Interim Award Funding Policy
The Department of Health and Human Services (HHS), including NIH, Continuing Appropriations and Ukraine Supplemental Appropriations Act (Public Law 117-180) signed by President Biden on September 30, 2022. This Act (CR) continues government operations through December 16, 2022 at the FY 2022 enacted level, with no reduction.
NIDDK extramural research is organized into 3 programmatic divisions: 1) Diabetes, Endocrinology, and Metabolic Diseases; 2) Digestive Diseases and Nutrition; and 3) Kidney, Urologic, and Hematologic Diseases.
Until FY 2023 appropriations are enacted, NIH will issue non-competing research grant awards at a level below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level). See https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-105.html for details.
- NIDDK will announce additional details regarding its interim FY 2023 funding policy, including details regarding funding of competing grant applications as information becomes available.